Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
German Catalysts MeetGerman Catalysts Meet
Not Confirmed
Not Confirmed
12-14 March, 2025
Not Confirmed
Not Confirmed
12-14 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
German Catalysts MeetGerman Catalysts Meet
Industry Trade Show
Not Confirmed
12-14 March, 2025
Industry Trade Show
Not Confirmed
12-14 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
10 Mar 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/notice-to-convene-annual-general-meeting-2025-997936
03 Mar 2025
// PRESS RELEASE
https://news.abbvie.com/2025-03-03-AbbVie-and-Gubra-Announce-License-Agreement-to-Develop-an-Amylin-Analog-for-the-Treatment-of-Obesity
13 Nov 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/gubras-amylin-obesity-asset-well-tolerated-tied-3-weight-loss-phase-1-trial
01 Jul 2024
// PRESS RELEASE
https://www.boehringer-ingelheim.com/science-innovation/human-health-innovation/phase-1-start-novel-triple-agonist-obesity-treatment
ABOUT THIS PAGE